China’s top commerce official said on Sunday that it has no intention to start a trade war with the United States and will not initiate one, but the country can cope with any challenge and will defend its national interests.
What’s needed is a much more open and inclusive process, to ensure that trade agreements such as NAFTA reflect the needs of all rather than just those of well-connected corporate lobbies.
On March 8, trade representatives from eleven Pacific rim countries including Canada, Mexico, Japan, and Australia are expected to ratify the Trans-Pacific Partnership, now known as the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). The agreement has been slimmed down both in its content—22 items in the text have been suspended, including the bulk of the intellectual property chapter—and also in its membership, with the exclusion of the United States which had been the driver of those suspended provisions.
The ongoing NAFTA renegotiation presents a prime opportunity to move the ball on protecting and promoting general public interest copyright exceptions.
We invite you to add your signatures to this document.
Japan’s role in RCEP negotiations appears to have been shaped by its participation in the TPP. Japan is now championing for expanded intellectual property right provisions which may block access to affordable medicines
Time and again, Canadians reaffirm their belief in the basic principle of equitable access to health care for all. But the spirit of this very Canadian principle remains in peril as NAFTA negotiations forge ahead.
As the Trans-Pacific Partnership (TPP) made significant headway in January, negotiating countries in the Regional Comprehensive Economic Partnership (RCEP) are pressured to conclude the trade deal, and they try to make progress in the ongoing talks in Indonesia.
India must resist pressure from Japan and South Korea in RCEP for the elevated levels of intellectual property provisions and make sure the deal doesn’t limit the production of life-saving generic drugs in India and for many other developing countries of the world.
AIDS, cancer, religious-based, teacher, and retiree advocacy groups were among the more than 100 organizations that recently signed a letter warning health and trade ministers of the United States, Canada, and Mexico not to undermine NAFTA’s access to affordable medicines.
The present Indian government has relaunched the talks with Israel. Israel wishes to conduct talks on regular basis to conclude the deal at the earliest. Indian patent system and pharmaceutical related issues have been the reasons why the deal couldn’t progress.
Reliance on digital technologies can further concentrate the market dominance of vertically integrated agribusinesses and transnational corporations who control national and global supply chains.
India’s position in the RCEP is the most protectionist among all the member nations. India has been resisting demands from Korea & Japan on intellectual property clauses, and other nations on opening up markets.
The US government’s role as a leader of the international intellectual property system is under self-imposed threat.
South Korean and India plan to jointly hold intellectual property rights (IPRs) in areas of manufacturing, energy and healthcare, as part of the negotiations for the bilateral trade agreement that the two countries recently reviewed
Negotiations are now nearing completion and there are increasing concerns among public health advocates, patient and consumer organisations, and other stakeholders, both in Europe and the Americas.
After two decades of intellectual property regimes in trade agreements, one could have some second thoughts.
Many of the intellectual property provisions raised by the European Union in this agreement are bad for internet users.
Free trade agreements represent a powerful source of pressure to privatise seeds and people’s knowledge connected to seeds.